GGrantIndex
Sort

15,842 grants matching pancreatic cancer

Targeting tumor-stromal interaction for pancreatic cancer therapy

$313,325
Ajay Pratap Singh · University Of South Alabama · R01 · FY2014 · CA

Novel Nanoparticle Therapy for Pancreatic Cancer

$313,269
Mark Kester · Pennsylvania State Univ Hershey Med Ctr · R01 · FY2013 · CA

The Antigen Targeting Core

$313,249
Maria Parkhurst · Division Of Basic Sciences - Nci · ZIC · FY2017 · CA

Mechanisms of immunomodulation with epigenetic therapy

$313,219
Nilofer S. Azad · Johns Hopkins University · P01 · FY2025 · CA

Mechanisms of immunomodulation with epigenetic therapy

$313,219
Nilofer S. Azad · Johns Hopkins University · P01 · FY2021 · CA

Novel Nanoparticle Therapy for Pancreatic Cancer

$313,204
Gail L. Matters · Pennsylvania State Univ Hershey Med Ctr · R01 · FY2015 · CA

Novel Nanoparticle Therapy for Pancreatic Cancer

$313,189
Gail L. Matters · Pennsylvania State Univ Hershey Med Ctr · R01 · FY2016 · CA

EASTERN COOPERATIVE ONCOLOGY GROUP

$313,134
Johns Hopkins University · U10 · FY2002 · CA

EASTERN COOPERATIVE ONCOLOGY GROUP

$313,134
Johns Hopkins University · U10 · FY2003 · CA

Novel Nanoparticle Therapy for Pancreatic Cancer

$313,134
Gail L. Matters · Pennsylvania State Univ Hershey Med Ctr · R01 · FY2017 · CA

Project 2 - Fatty Liver Predisposes to Metastasis: Role of Hepatic Stellate Cells

$313,104
Ekihiro Seki · Cedars-Sinai Medical Center · P01 · FY2023 · CA

Biochemical and molecular studies on NQO1. Design of less toxic Hsp90 inhibitors

$312,983
David Ross · University Of Colorado Denver · R01 · FY2017 · CA

Serum glycoprotein markers of cancer using an ion mobility/mass spec approach

$312,911
David M. Lubman · University Of Michigan At Ann Arbor · R01 · FY2011 · CA

RIBONUCLEASES IN CANCER CHEMOTHERAPY

$312,841
Ronald T Raines · University Of Wisconsin-Madison · R01 · FY2006 · CA

Neurofibromatosis type 1 Gene Regulates Myelopoiesis

$312,768
David W. Clapp · Indiana University Indianapolis · R01 · FY2012 · CA

Enhancing the Biomedical Computing Platform for Pancreatic Cancer Research

$312,707
Simon Sherman · University Of Nebraska Medical Center · R01 · FY2010 · CA

Suppression of pancreatic tumorigenesis by the PTF1 transcription factor network

$312,680
Lewis C Murtaugh · University Of Utah · R01 · FY2019 · CA

Dissecting Hedgehog, TGF beta and BMP Signaling During Pancreatic Tumorigenesis

$312,660
Brian C Lewis · Univ Of Massachusetts Med Sch Worcester · R01 · FY2014 · CA

DPC4 TARGET OF 18Q HOMOZYGOUS DELETIONS IN PANCREATIC CA

$312,628
Johns Hopkins University · R01 · FY2001 · CA

T Cell Immunity to Epithelial Tumor Mucins

$312,611
Olivera J Finn · University Of Pittsburgh At Pittsburgh · R01 · FY2011 · CA

Project 2: Clinical Development of the Pancreatic Cancer Drug Conjugate SW v-49

$312,611
William G Hawkins · Washington University · P50 · FY2017 · CA

T Cell Immunity to Epithelial Tumor Mucins

$312,611
Olivera J Finn · University Of Pittsburgh At Pittsburgh · R01 · FY2012 · CA

Kras-Induced Cellular Plasticity in Pancreatic Cancer

$312,577
Stephen F Konieczny · Purdue University · R01 · FY2016 · CA

4D IMRT: Stereotactic body radiotherapy for lung cancer

$312,504
Paul J Keall · Stanford University · R01 · FY2010 · CA

Kras-Induced Cellular Plasticity in Pancreatic Cancer

$312,367
Stephen F Konieczny · Purdue University · R01 · FY2017 · CA